Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA's Policy Development and Coordination Staff

This article was originally published in The Gray Sheet

Executive Summary

Director David Adams is leaving the agency in May to join the Washington, D.C. office of Margan, Lewis & Blockus, an international law firm. Adams, 42, joined FDA in 1978 as associate chief counsel for enforcement and trial attorney. From 1985 to 1992, Adams served as associate chief counsel for drugs and, in January 1992, went to the Office of the Commissioner. FDA policies Adams has been involved with include application integrity and industry-supported scientific and educational activities

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002231

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel